Description
| BRAND NAME | MANUFACTURER |
| DACLAHEP | Hetero Drugs Ltd |
| DAKLINZA | Bristol Myers Squibb |
| MYDACLA | Mylan Pharmaceuticals Pvt Ltd |
| NATDAC | Natco Pharma Ltd |
Daclatasvir
Daclatasvir is recommended as a treatment for adults with some genotypes of chronic hepatitis C, depending on their level of fibrosis. It is taken with sofosbuvir and sometimes with ribavirin.
